QuidelOrtho (QDEL) Stock Forecast & Price Target $12.39 +0.48 (+4.03%) Closing price 05/21/2026 04:00 PM EasternExtended Trading$12.36 -0.03 (-0.27%) As of 05/21/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QuidelOrtho - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating ReduceBased on 6 Analyst RatingsSell3Hold3Buy0 Based on 6 Wall Street analysts who have issued ratings for QuidelOrtho in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 6 analysts, 3 have given a sell rating, and 3 have given a hold rating for QDEL. Consensus Price Target $14.8820.06% Upside According to the 6 analysts' twelve-month price targets for QuidelOrtho, the average price target is $14.88. The highest price target for QDEL is $22.00, while the lowest price target for QDEL is $12.00. The average price target represents a forecasted upside of 20.06% from the current price of $12.39. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for QDEL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for QuidelOrtho and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QDEL Analyst Ratings Over TimeTypeCurrent Forecast5/22/25 to 5/22/261 Month Ago4/22/25 to 4/22/263 Months Ago2/21/25 to 2/21/261 Year Ago5/22/24 to 5/22/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)1 Buy rating(s)1 Buy rating(s)4 Buy rating(s)Hold3 Hold rating(s)2 Hold rating(s)2 Hold rating(s)2 Hold rating(s)Sell3 Sell rating(s)3 Sell rating(s)3 Sell rating(s)1 Sell rating(s)Consensus Price Target$14.88$28.25$31.50$44.33Forecasted Upside20.06% Upside137.39% Upside40.12% Upside46.90% UpsideConsensus RatingReduceReduceReduceHold QDEL Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History QDEL Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table QuidelOrtho Stock vs. The CompetitionTypeQuidelOrthoMedical CompaniesBroader MarketConsensus Rating Score 1.50 2.29 2.52Consensus RatingReduceHoldModerate BuyPredicted Upside20.06% Upside1,718.29% Upside15.96% UpsideNews Sentiment RatingNeutral NewsSee Recent QDEL NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails5/7/2026 UBS Group4 of 5 starsLu LiNot RatedReiterated RatingNeutral$12.00+11.47%5/7/2026 Jefferies Financial Group2 of 5 starsTycho Peterson2 of 5 starsDowngradeBuy ➝ Hold$35.00 ➝ $12.50+14.05%5/6/2026 Citigroup4 of 5 starsPatrick Donnelly4 of 5 starsLower TargetNeutral$30.00 ➝ $13.00+17.18%4/21/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingSell (E+)2/17/2026 Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeHold ➝ Strong Sell11/7/2025 JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCasey WoodringSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetUnderweight$26.00 ➝ $22.00+8.26%2/13/2025 Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingConor McNamaraSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOutperform$64.00 ➝ $61.00+45.55%11/20/2024 William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingMarket Perform9/5/2024 Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBill BonelloSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeHold ➝ Buy$40.00 ➝ $57.00+41.23%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:48 AM ET. QDEL Forecast - Frequently Asked Questions What is QuidelOrtho's forecast for 2026? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for QuidelOrtho is $14.88, with a high forecast of $22.00 and a low forecast of $12.00. Should I buy or sell QuidelOrtho stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 3 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" QDEL shares. Does QuidelOrtho's stock price have much upside? According to analysts, QuidelOrtho's stock has a predicted upside of 20.06% based on their 12-month stock forecasts. Has QuidelOrtho been downgraded by Wall Street analysts recently? Over the previous 90 days, QuidelOrtho's stock had 1 downgrade by analysts. What analysts cover QuidelOrtho? QuidelOrtho has been rated by research analysts at Citigroup, Jefferies Financial Group, UBS Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like QuidelOrtho more than its competitors? Analysts like QuidelOrtho less than other "medical" companies. The consensus rating for QuidelOrtho is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how QDEL compares to other companies. Stock Forecasts and Research Tools Related Companies HAE Stock Forecast XRAY Stock Forecast NEOG Stock Forecast STAA Stock Forecast CERS Stock Forecast OSUR Stock Forecast UTMD Stock Forecast ANIK Stock Forecast WST Stock Forecast ALGN Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With QuidelOrtho RecommendationsUBS GroupJefferies Financial GroupCitigroupWeiss RatingsWall Street ZenZacks ResearchJPMorgan Chase & Co. This page (NASDAQ:QDEL) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredI had never heard of this 1888 accountAn investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...The Oxford Club | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredHow to Profit from Elon’s AI lab before it goes publicElon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...InvestorPlace | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QuidelOrtho Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share QuidelOrtho With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
